BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30916432)

  • 1. A comparison of common practices for identifying substance use during pregnancy in obstetric clinics.
    Klawans MR; Northrup TF; Villarreal YR; Berens PD; Blackwell S; Bunag T; Stotts AL
    Birth; 2019 Dec; 46(4):663-669. PubMed ID: 30916432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perinatal Illicit Drug and Marijuana Use.
    Chang JC; Holland CL; Tarr JA; Rubio D; Rodriguez KL; Kraemer KL; Day N; Arnold RM
    Am J Health Promot; 2017 Jan; 31(1):35-42. PubMed ID: 26559718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal substance use in a Western urban community.
    Buchi KF; Varner MW
    West J Med; 1994 Nov; 161(5):483-6. PubMed ID: 7810126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette, alcohol and other drug use among small city pregnant adolescents.
    Kokotailo PK; Langhough RE; Cox NS; Davidson SR; Fleming MF
    J Adolesc Health; 1994 Jul; 15(5):366-73. PubMed ID: 7947850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A descriptive regional study of drug and alcohol use in pregnant women using results from urine drug testing by liquid chromatography-tandem mass spectrometry.
    Kreshak A; Villano J; Clark A; Deak P; Clark R; Miller C
    Am J Drug Alcohol Abuse; 2016 Mar; 42(2):178-86. PubMed ID: 26811262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for substance abuse in pregnancy.
    Jimerson SD; Musick S
    J Okla State Med Assoc; 2013 Apr; 106(4):133-4. PubMed ID: 23795524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Antenatal Maternal Self-reported Substance Use, Maternal Characteristics, and Obstetrical Variables.
    Berra A; Kamo S; Mohnot S; Rosselot J; Suire A; Stafford J; Hagan J; Stafford I
    J Addict Med; 2019; 13(6):464-469. PubMed ID: 31033670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of Self-Reported Drug Use Information Among Pregnant Women.
    Garg M; Garrison L; Leeman L; Hamidovic A; Borrego M; Rayburn WF; Bakhireva L
    Matern Child Health J; 2016 Jan; 20(1):41-47. PubMed ID: 26175273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of five self-report screening instruments for substance use in pregnancy.
    Ondersma SJ; Chang G; Blake-Lamb T; Gilstad-Hayden K; Orav J; Beatty JR; Goyert GL; Yonkers KA
    Addiction; 2019 Sep; 114(9):1683-1693. PubMed ID: 31216102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported alcohol and drug use in pregnant young women: a pilot study of associated factors and identification.
    Chang G; Orav EJ; Jones JA; Buynitsky T; Gonzalez S; Wilkins-Haug L
    J Addict Med; 2011 Sep; 5(3):221-6. PubMed ID: 21844837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison and validation of screening tools for substance use in pregnancy: a cross-sectional study conducted in Maryland prenatal clinics.
    Coleman-Cowger VH; Oga EA; Peters EN; Trocin K; Koszowski B; Mark K
    BMJ Open; 2018 Feb; 8(2):e020248. PubMed ID: 29455170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug screening during pregnancy: Urine dip cups measure up.
    Kroska EB; Meller EW; Doyle R; Coker JL; Knight BT; Ray-Griffith SL; Nembhard WN; Stowe ZN
    Drug Alcohol Depend; 2019 Nov; 204():107461. PubMed ID: 31521952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal screening for substance abuse at the time of parturition.
    Azadi A; Dildy GA
    Am J Obstet Gynecol; 2008 May; 198(5):e30-2. PubMed ID: 18279831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance use.
    Christmas JT; Knisely JS; Dawson KS; Dinsmoor MJ; Weber SE; Schnoll SH
    Obstet Gynecol; 1992 Nov; 80(5):750-4. PubMed ID: 1407909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of illicit drugs detected in the urine of women of childbearing age in Alabama public health clinics.
    Pegues DA; Engelgau MM; Woernle CH
    Public Health Rep; 1994; 109(4):530-8. PubMed ID: 8041853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antenatal psychiatric illness and adequacy of prenatal care in an ethnically diverse inner-city obstetric population.
    Kim HG; Mandell M; Crandall C; Kuskowski MA; Dieperink B; Buchberger RL
    Arch Womens Ment Health; 2006 Mar; 9(2):103-7. PubMed ID: 16380813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of substance misuse during early pregnancy in Blyth: an anonymous unlinked study.
    Sanaullah F; Gillian M; Lavin T
    J Obstet Gynaecol; 2006 Apr; 26(3):187-90. PubMed ID: 16698620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of substance abuse among pregnant women in Utah.
    Buchi KF; Varner MW; Chase RA
    Obstet Gynecol; 1993 Feb; 81(2):239-42. PubMed ID: 8423958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics.
    Kelly R; Zatzick D; Anders T
    Am J Psychiatry; 2001 Feb; 158(2):213-9. PubMed ID: 11156803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.